Trial reportImplementation science : IS2026
A comparative effectiveness trial for universal psychosocial screening with the Psychosocial Assessment Tool (PAT) across 18 childhood cancer programs in the United States: adoption, penetration, and health equity.
Trial report in Implementation science : IS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04446728 (Implementation of Family Psychosocial Risk Assessment in Pediatric Cancer With The Psychosocial Assessment Tool), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Implementation of Family Psychosocial Risk Assessment in Pediatric Cancer With The Psychosocial Assessment Tool (PAT)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundUniversal, systematic psychosocial screening in childhood cancer assures care matched to need and achieves a Standard of Psychosocial Care. It is accomplished inconsistently due to barriers at the family, provider, and institution level, potentially contributing to disparities in care and outcomes. We conducted a comparative effectiveness trial of two implementation strategies of an established measure (Psychosocial Assessment Tool; PAT3.0) across 18 children's cancer programs to identify strategies that resulted in higher levels of screening in English and Spanish (penetration, health equity). We also examined uptake at the institution level (adoption).
methodsSites were randomized to Strategy I (web-based training curriculum [WebTC] + a written, site-specific Implementation Plan) or Strategy II (Strategy I + Consultation Calls + a Champion) and to one of three year-long cohorts. Randomization was stratified by site size (new patients/year (small [< 50], medium [50-149], large [> 150]). Sites provided data to a central data coordinating site, including eligible and screened patients/families and type of insurance as a proxy for socioeconomic status (SES). ANOVAs compared percentage of eligible patients/families screened, eligible Hispanic patients/families screened, patients/families screened by identified race, patients/families screened by SES, and feedback provided to families across Strategy. Data from a WebTC feedback form and the sites' PAT implementation plans were summarized.
resultsThere were no differences between Strategy I and II in percentage of patients/families screened for 1) all eligible families; 2) Hispanic families; 3) identified race; 4) SES; and 5) feedback provided. Exploratory analyses examining strategy by size by cohort, identified lower percentages of patients/families screened in the second cohort. The WebTC was rated as clear and helpful in understanding the importance of screening and how to screen as part of workflow. On the PAT Implementation Plan, most sites screened a subsample of their cancer program population (e.g., inpatients, hematologic malignancies) with social workers or psychologists as screeners.
conclusionsComprehensive web-based training + Implementation Plan supported implementation of an established psychosocial screener, inclusive of racial and ethnic minoritized, English and Spanish-speaking, and lower SES patients/families. Implementation planning to address barriers at the patient, providers, and institution levels is indicated for successful screening of all patients and as part of childhood cancer program efforts to meet the Psychosocial Standards.
trial registrationClinicalTrials.gov, NCT04446728, registered 23 June 2020. https://clinicaltrials.gov/study/NCT04446728 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.